Pediatric research and the return of individual research results

Denise Avard1, Karine Sénécal, Parvaz Madadi

  • 1Centre of Genomics and Policy at McGill University, Canada.

Insights

Returning individual research results to children involves complex ethical considerations. This article reviews guidelines and literature to propose a framework for pediatric research result disclosure.

Area of Science:

  • Pediatric Research Ethics
  • Bioethics
  • Clinical Research Governance

Background:

  • Returning individual research results to participants presents ethical challenges, particularly in pediatric research.
  • Existing ethical guidelines and literature on this topic are limited.
  • Societal and ethical implications necessitate careful consideration when disclosing results to child participants.

Purpose of the Study:

  • To provide an overview of existing ethical guidelines and literature concerning the return of individual results in pediatric research.
  • To identify overarching considerations and contextual issues related to this practice.
  • To propose a framework to guide ethical decision-making in returning pediatric research findings.

Main Methods:

  • Systematic review of policies and relevant academic literature.
  • Analysis of ethical considerations and socio-ethical issues.
  • Synthesis of information to develop a proposed framework.

Main Results:

  • Limited existing ethical guidelines specifically address returning individual results in pediatric research.
  • Key considerations include participant assent/consent, potential for psychological harm, and data interpretation.
  • Contextual factors such as the nature of the results and family dynamics are crucial.

Conclusions:

  • A comprehensive framework is needed to navigate the complexities of returning individual research results in pediatric studies.
  • Ethical practice requires balancing the potential benefits of result disclosure with the risks to child participants and their families.
  • Further research and policy development are warranted to support ethical best practices.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.